nonmelanoma skin cancer

nonmelanoma skin cancer

1. Basal cell carcinoma, see there.
2. Squamous cell cancer, see there.
3. Skin adnexal carcinoma.
4. Cutaneous lymphoma.
References in periodicals archive ?
A 97-year-old woman with a history of atrial fibrillation and nonmelanoma skin cancer presented to our clinic from an assisted living facility with a several-month history of rapidly growing forehead lesions.
PR35 the incidence of nonmelanoma skin cancer in New Zealand.
Nonmelanoma skin cancer (NMSC) is the most common type of cancer in Turkey, and its incidence is rising across the world.
Biopharmaceutical company Sirnaomics Inc reported on Thursday the receipt of the US Food and Drug Administration's (FDA) approval for its proposed Phase 2 clinical study to evaluate its lead product candidate, STP705, for the treatment of in situ Squamous Cell Carcinoma Nonmelanoma Skin Cancer (NMSC).
It's time for "keratinocyte carcinoma" to replace the term "nonmelanoma skin cancer." J Am Acad Dermatol 2015; 72: 186-187.
Abundant evidence indicates there is an ongoing epidemic of nonmelanoma skin cancer (NMSC) in the United States--and it is associated with a surprising amount of morbidity and mortality, the dermatologic surgeon observed.
Advanced CSCC, the deadliest nonmelanoma skin cancer, encompasses both patients with metastatic CSCC and those with locally advanced CSCC who are not candidates for surgery; there is currently no approved treatment for these patients.
After studying more than 900 cases of melanoma reported through the Health Professionals Follow-up Study, researchers found that men with a history of nonmelanoma skin cancer were less likely to die of melanoma than those without such history.
Compared with those screened by a dermatologist, patients screened by a PA were significantly less likely to be diagnosed with melanoma in situ (1.1 versus 1.8 percent of visits; P = 0.02); for invasive melanoma (0.7 versus 0.8 percent of visits; P = 0.83) and nonmelanoma skin cancer (6.1 versus 6.1 percent of visits; P = 0.98), the differences were not significant.
Cohen, "Topical and intralesional treatment of nonmelanoma skin cancer: Efficacy and cost comparisons," Dermatologic Surgery, vol.
It would be expected that this patient presenting with a nonmelanoma skin cancer would have had pathology in areas with more cumulative ultraviolet exposure such as the face, hands, arms, and upper chest.
Weinstock, "Nonmelanoma skin cancer in the United States: incidence," Journal of the American Academy of Dermatology, vol.